163 related articles for article (PubMed ID: 31189758)
1. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.
Takesue Y; Wei FY; Fukuda H; Tanoue Y; Yamamoto T; Chujo T; Shinojima N; Yano S; Morioka M; Mukasa A; Kuratsu J; Tomizawa K
Endocr J; 2019 Sep; 66(9):807-816. PubMed ID: 31189758
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
3. Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.
Ashton C; Rhie SK; Carmichael JD; Zada G
J Neurosurg; 2020 Feb; 134(3):787-793. PubMed ID: 32109873
[TBL] [Abstract][Full Text] [Related]
4. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
5. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
[TBL] [Abstract][Full Text] [Related]
6. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
[TBL] [Abstract][Full Text] [Related]
7. Expression of the long non-coding RNA H19 and MALAT-1 in growth hormone-secreting pituitary adenomas and its relationship to tumor behavior.
Lu T; Yu C; Ni H; Liang W; Yan H; Jin W
Int J Dev Neurosci; 2018 Jun; 67():46-50. PubMed ID: 29604339
[TBL] [Abstract][Full Text] [Related]
8. Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.
Sakai N; Kim K; Sanno N; Yoshida D; Teramoto A; Shibasaki T
Neurol Med Chir (Tokyo); 2008; 48(11):481-7; discussion 487-8. PubMed ID: 19029774
[TBL] [Abstract][Full Text] [Related]
9. The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells.
Occhi G; Losa M; Albiger N; Trivellin G; Regazzo D; Scanarini M; Monteserin-Garcia JL; Fröhlich B; Ferasin S; Terreni MR; Fassina A; Vitiello L; Stalla G; Mantero F; Scaroni C
J Neuroendocrinol; 2011 Jul; 23(7):641-9. PubMed ID: 21554434
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
[TBL] [Abstract][Full Text] [Related]
13. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas.
He Z; Chen L; Hu X; Tang J; He L; Hu J; Fei F; Wang Q
Endocr J; 2019 Aug; 66(8):709-722. PubMed ID: 31061247
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits proliferation and growth hormone secretion of GH3 pituitary adenoma cells.
An J; Pei X; Zang Z; Zhou Z; Hu J; Zheng X; Zhang Y; He J; Duan L; Shen R; Zhang W; Zhu F; Li S; Yang H
Oncotarget; 2017 Jun; 8(23):37538-37549. PubMed ID: 28380462
[TBL] [Abstract][Full Text] [Related]
16. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
[TBL] [Abstract][Full Text] [Related]
17. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
18. Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype.
Chen Y; Gao H; Xie W; Guo J; Fang Q; Zhao P; Liu C; Zhu H; Wang Z; Wang J; Gui S; Zhang Y; Li C
Aging (Albany NY); 2020 Dec; 13(1):1276-1293. PubMed ID: 33472173
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives.
Guaraldi F; Ambrosi F; Ricci C; Di Sciascio L; Asioli S
Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101894. PubMed ID: 38614953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
